Shijiazhuang Yiling Pharmaceutical Co., Ltd. is a national key high-tech enterprise founded by Wu Yiling, an academician of China Academy of Engineering. Under his leadership, Yiling Pharmaceutical has always adhered to the scientific and technological innovation development strategy with science and technology as the guide and market as the leading factor, and established an innovative technology system for new drug research and development oriented to the theoretical innovation of collateral diseases in traditional Chinese medicine.
Yiling Pharmaceutical was listed on the A-share market on July 28th, 20 1 1. Shijiazhuang Yiling Pharmaceutical Co., Ltd. is an enterprise mainly engaged in research and development, production and sales of Chinese patent medicines. At present, its most famous product is Lianhua Qingwen Capsule. The company has obtained 29 domestic invention patents and utility model patents, 2 international invention patents and 17 authorized design patents.
Requirements for listing of companies
1. Only joint-stock companies are eligible for listing;
2. To apply for listing as a company, the company must operate for more than 3 years, and there has been no change of directors or senior management personnel in these 3 years. The company operates legally and conforms to national laws and regulations;
3. There is no false capital contribution in the registered capital of listed companies, and there is no phenomenon of withdrawing capital contribution;
4. Listed companies mainly raise funds, but the funds raised must be strictly used before, so the key point is to strictly check whether the company has the listing conditions.